WORLDWIDE CLINICAL-EXPERIENCE WITH CEFOPERAZONE

被引：22
作者：
GERBER, AU
CRAIG, WA
机构：
[1] WILLIAM S MIDDLETON MEM VET ADM HOSP,DEPT MED,MED SERV,MADISON,WI 53705
[2] UNIV WISCONSIN,DEPT MED,MADISON,WI 53706
来源：
DRUGS | 1981年 / 22卷
关键词：
D O I：
10.2165/00003495-198100221-00022
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：108 / 118
页数：11
相关论文
共 10 条
[1]  
BUNDTZEN RW, 1981, REV INFECT DIS, V3, P28
[2]  
CRAIG WA, 1980, CLIN THER, V3, P46
[3]   PROTEIN-BINDING OF ANTIMICROBIALS - CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS [J].
CRAIG, WA ;
WELLING, PG .
CLINICAL PHARMACOKINETICS, 1977, 2 (04) :252-268
[4]  
JONES RN, 1980, CURRENT CHEMOTHERAPY, V1, P179
[5]   SUSCEPTIBILITIES OF ANAEROBIC-BACTERIA TO CEFOPERAZONE AND OTHER ANTIBIOTICS [J].
KAYE, D ;
KOBASA, W ;
KAYE, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) :957-960
[6]  
MASHIMO K, 1980, CLIN THER, V3, P159
[7]  
MATSUMOTO K, 1980, CURRENT CHEMOTHERAPY, V1, P169
[8]  
NISHIURA T, 1980, CLIN THER, V3, P190
[9]  
SHIBATA K, 1980, CLIN THER, V3, P173
[10]  
UEDA Y, 1980, CURRENT CHEMOTHERAPY, V1, P165
1